San Francisco, California, United States Berkeley Catalyst Fund (BCF) is the famous VC, which was founded in 2015. The company was established in North America in United States. The main department of described VC is located in the San Francisco.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Nanotechnology, Genetics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline 4D Molecular Therapeutics, Nelumbo
The important activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Berkeley Catalyst Fund (BCF), startups are often financed by SOSV, IndieBio, Cystic Fibrosis Foundation. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, University of Michigan MINTS fund, UPC Renewables. In the next rounds fund is usually obtained by SOSV, IndieBio.
Besides them, we counted 2 critical employees of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Accretion Capital | Florida, Miami, United States |
| Alpha Holdings | Kyonggi-do, Pangyo, South Korea |
| CardConnect | King Of Prussia, Pennsylvania, United States |
| Lippo Group | Banten, Indonesia, Jawa Barat |
| Mindao Touzi | China, Guangdong, Jiangxi |
| Sanluwu Zaixian Yiliao Keji | Beijing, China, Haidian |
| Shanghai Qiguang Touzi | China, Shanghai |
| Strathmere Healthcare Partners | - |
| Times Mirror Corporation | Charlotte, North Carolina, United States |
| Toronto Innovation Acceleration Partners | Canada, Ontario, Toronto |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PrinterPrezz | $52M | 07 Mar 2023 | Fremont, California, United States | ||
Telesair | $22M | 10 Jan 2023 | Irvine, California, United States | ||
Valitor | $28M | 05 Oct 2022 | Berkeley, California, United States | ||
Vicinitas Therapeutics | $65M | 28 Jul 2022 | San Francisco, California, United States | ||
Arima Genomics | $7M | 15 Mar 2022 | San Diego, California, United States | ||
Akadeum Life Sciences | $17M | 12 Oct 2021 | Ann Arbor, Michigan, United States | ||
Acrigen Biosciences | 28 Sep 2021 | Berkeley, California, United States | |||
Filtricine | 03 Aug 2021 | San Jose, California, United States | |||
Amplicore | $4M | 25 Mar 2021 | Illinois, United States |
– Amplicore from Cincinnati develops minimally invasive therapeutic solutions for musculoskeletal diseases.
– The company closed its $4m seed round of funding.
– The round was led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital.
– The new investment will be used to complete the preclinical development of the company’s two leading products, AM3101 and AM1101, and position itself for the next round of financing.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PrinterPrezz | $52M | 07 Mar 2023 | Fremont, California, United States | ||
Telesair | $22M | 10 Jan 2023 | Irvine, California, United States | ||
Valitor | $28M | 05 Oct 2022 | Berkeley, California, United States | ||
Vicinitas Therapeutics | $65M | 28 Jul 2022 | San Francisco, California, United States | ||
Arima Genomics | $7M | 15 Mar 2022 | San Diego, California, United States | ||
Akadeum Life Sciences | $17M | 12 Oct 2021 | Ann Arbor, Michigan, United States | ||
Acrigen Biosciences | 28 Sep 2021 | Berkeley, California, United States | |||
Filtricine | 03 Aug 2021 | San Jose, California, United States | |||
Amplicore | $4M | 25 Mar 2021 | Illinois, United States |
